4//SEC Filing
Hicks Laurence 4
Accession 0001415889-22-007594
CIK 0001537561other
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 4:53 PM ET
Size
10.3 KB
Accession
0001415889-22-007594
Insider Transaction Report
Form 4
Hicks Laurence
Director
Transactions
- Award
Senior Secured Convertible Notes
2022-07-06+36,000→ Common Stock (787,746 underlying) - Award
Warrants
2022-07-06+724,346→ 724,346 totalExercise: $0.05From: 2022-07-06Exp: 2027-07-06→ Common Stock (724,346 underlying) - Award
Common Stock
2022-07-06+108,652→ 108,652 total(indirect: By LLC)
Footnotes (4)
- [F1]The shares of common stock, senior secured convertible notes (the "Notes") and warrants were issued to the Reporting Person in connection with a convertible note offering entered into by the Reporting Person and the Issuer (the "Offering"), which Offering was approved by the Issuer's Board of Directors and, in accordance with Rule 16b-3(d)(1) of the Exchange Act (the "Act"), is exempt from Section 16(b) of the Act pursuant to Rule 16b-3(e) promulgated thereunder.
- [F2]As a managing member of Drake Partners Equity, LLC, the Reporting Person may be determined to have beneficial ownership of the shares reported herein.
- [F3]The Notes become due and payable on January 6, 2024, bear interest at a rate of 10% per annum, are convertible at the option of the holder pursuant to certain provisions with an initial conversion price of $0.0457, contain customary events of default and are subject to certain beneficial ownership limitations.
- [F4]Conversion of the warrants is subject to certain beneficial ownership limitations.
Documents
Issuer
Arch Therapeutics, Inc.
CIK 0001537561
Entity typeother
Related Parties
1- filerCIK 0001886766
Filing Metadata
- Form type
- 4
- Filed
- Jul 7, 8:00 PM ET
- Accepted
- Jul 8, 4:53 PM ET
- Size
- 10.3 KB